Crossover operators for molecular graphs with an application to virtual drug screening
Genetic algorithms are a powerful method to solve optimization problems with complex cost functions over vast search spaces that rely in particular on recombining parts of previous solutions. Crossover operators play a crucial role in this context. Here, we describe a large class of these operators designed for searching over spaces of graphs. These operators are based on introducing small cuts into graphs and rejoining the resulting induced subgraphs of two parents. This form of cut-and-join crossover can be restricted in a consistent way to preserve local properties such as vertex-degrees (valency), or bond-orders, as well as global properties such as graph-theoretic planarity. In contrast to crossover on strings, cut-and-join crossover on graphs is powerful enough to ergodically explore chemical space even in the absence of mutation operators. Extensive benchmarking shows that the offspring of molecular graphs are again plausible molecules with high probability, while at the same time crossover drastically increases the diversity compared to initial molecule libraries. Moreover, desirable properties such as favorable indices of synthesizability are preserved with sufficient frequency that candidate offsprings can be filtered efficiently for such properties. As an application we utilized the cut-and-join crossover in REvoLd, a GA-based system for computer-aided drug design. In optimization runs searching for ligands binding to four different target proteins we consistently found candidate molecules with binding constants exceeding the best known binders as well as candidates found in make-on-demand libraries.Scientific contributionWe define cut-and-join crossover operators on a variety of graph classes including molecular graphs. This constitutes a mathematically simple and well-characterized approach to recombination of molecules that performed very well in real-life CADD tasks.
Authors
- Peter F. Stadler (ORCID: https://orcid.org/0000-0002-5016-5191)
- Thomas Gatter (ORCID: https://orcid.org/0000-0001-5567-3016)
- Bruno E. Schmidt (ORCID: https://orcid.org/0000-0002-6186-8538)
- Jens Meiler (ORCID: https://orcid.org/0000-0001-8945-193X)
- Richard Golnik (ORCID: https://orcid.org/0000-0002-8582-5006)
- Fabian Ließmann (ORCID: https://orcid.org/0009-0007-9199-1629)
- Paul Eisenhuth (ORCID: https://orcid.org/0009-0006-7379-5096)
- Nico Domschke
Institutions
- University of Vienna (AT)
- Santa Fe Institute (US)
- Leipzig University of Applied Sciences (DE)
- Vanderbilt University (US)
- Universidad Nacional de Colombia (CO)
- Max Planck Institute for Mathematics in the Sciences (DE)
- Max Planck Institute for Mathematics (DE)
- Artificial Intelligence in Medicine (Canada) (CA)
- Leipzig University (DE)
Publication Details
- Journal
- Journal of Cheminformatics
- Published
- 2025-06-17
- DOI
- https://doi.org/10.1186/s13321-025-00958-w
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Alexander von Humboldt-Stiftung
- Max Kade Foundation
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
- Universität Leipzig
- Novo Nordisk Fonden
- German Network for Bioinformatics Infrastructure